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INTRODUCTION: Modem approach to leukemia treatment include using of 
the citostatics complex, that allows to attain clinico-hematological remissions of 
acute leukemia and increase duration and life quality of these pts. However 
citotoxicity on the mucous barrier of gastroduodenal zone (MBGDZ) is not always 
taken into account. AIMS & METHODS: The aim is to study efficiency of 
Pantoprazole (P) and Rebamipide (R) in complex treatment of pts with acute and 
chronic leukemia with ulcer disease of duodenum (UDD) and to evaluate their 
influence on resistance of MBGDZ. • 
34 pts suffering from acute and chronic leukemia with concomitant UDD, 
associated with Helicobacter pylori (HP), were devided in 2 groups: I (n = 18) recieved 
antiheli- cobacter therapy (AHBT), including P 80mg/day - 10 days; P 40 mg up to 28 
days; II (n= 16) - AHBT+R 300mg/day 28 days. All pts recieved basic citostatic therapy 
for the basic disease. 
RESULTS: Clinico-endoscopic remission of UDD in 28 days was registered 
in 15 (83.3%) pts I and 15 (93.7%) pts of group II. Eradication of HP was attained 
at 14 (77.7%) pts I, 15 (93.7%) pts of group II. 
Concentration of fucose, related to the albumen, in blood semm in pts before 
treatment 2.8 times lower than norm, and on the background of the therapy 
increased in 1.6 time in group I (0.32±0.07 mmol/1) and in 1.8 time in group II 
(0.4±0.07 mmol/1; p < 0.05), not reaching to the indexes of norm, NANA blood 
concentration in 1.6 time exceeded the indexes of norm, and after treatment 
diminished in 1.2 time in pts group I and in 1.3 time in group II (p < 0.05). Level 
of NANA excretion with urine in 1.5 time higher before treatment, went down in 
group I after treatment in 1.3 time, in group II - in 1.7 time (p < 0.05). The level of 
fucose excretion with urine after treatment rose in group I in 1.3 time, in group II - 
in 1.5 time. 
The structure of cell’s mitochondrias of main glands of stomach is 
normalized on the background of treatment, parietal cells are in a state of low 
functional activity, and mucoid cells of mucous membrane of stomach (MMS) - in 
a state of high functional activity. The maximally expressed improvements of 
morphological picture of MMS are set in group II. 
CONCLUSION: MBGDZ resistance considerably goes down in pts who 
suffer with leukemia, taking into account as influence of disease as damage of 
basic citostatic therapy on the mucous barrier which renders a 
membranedestructive effect, weakens citoprotection, violates circulation of blood 
in mucous membrane. 
P in composition with AHBT and R are increase protective albumens 
synthesis of MBGDZ, decrease degradation of sialo- and increase fucoproteins 
production, determining its resistance. P and R are important components of 
accompanying therapy in pts with leukemia which effectively reduce frequency of 
erosive and ulcerative lesions of MBGDZ in complex with antisecretory 
preparations. 
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